Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 26, 2026.

Evaluation of the Association between Maternal Smoking, Childhood Obesity, and Metabolic Disorders: A National Toxicology Program Workshop Review

Mamta Behl, Deepa Rao, Kjersti Aagaard and 9 more

Environmental Health Perspectives · 2012 · Review · Public domain

doi:10.1289/ehp.1205404

Abstract

Background: An emerging literature suggests that environmental chemicals may play a role in the development of childhood obesity and metabolic disorders, especially when exposure occurs early in life. Objective: Here we assess the association between these health outcomes and exposure to maternal smoking during pregnancy as part of a broader effort to develop a research agenda to better understand the role of environmental chemicals as potential risk factors for obesity and metabolic disorders. Methods: PubMed was searched up to 8 March 2012 for epidemiological and experimental animal studies related to maternal smoking or nicotine exposure during pregnancy and childhood obesity or metabolic disorders at any age. A total of 101 studies—83 in humans and 18 in animals—were identified as the primary literature. Discussion: Current epidemiological data support a positive association between maternal smoking and increased risk of obesity or overweight in offspring. The data strongly suggest a causal relation, although the possibility that the association is attributable to unmeasured residual confounding cannot be completely ruled out. This conclusion is supported by findings from laboratory animals exposed to nicotine during development. The existing literature on human exposures does not support an association between maternal smoking during pregnancy and type 1 diabetes in offspring. Too few human studies have assessed outcomes related to type 2 diabetes or metabolic syndrome to reach conclusions based on patterns of findings. There may be a number of mechanistic pathways important for the development of aberrant metabolic outcomes following perinatal exposure to cigarette smoke, which remain largely unexplored. Conclusions: From a toxicological perspective, the linkages between maternal smoking during pregnancy and childhood overweight/obesity provide proof-of-concept of how early-life exposure to an environmental toxicant can be a risk factor for childhood obesity.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 26, 2026. Paragraph numbers are ours, so an answer can point at one.

Childhood obesity and diabetes are major threats to public health in the United States and abroad. In the United States, the prevalence of obesity among children and adolescents has almost tripled since 1980, with an estimated 16.9% of children and adolescents (i.e., approximately 12.5 million children and adolescents) considered obese. This trend is also apparent in preschool children 2–5 years of age, where obesity was shown to have increased from 5% in 1976–1980 to 10.4% in 2007–2008. reported an almost doubling in the prevalence of overweight in infants 0–6 months of age from 1980 to 2001 (3.4% to 5.9%) based on information from well-child visits at a large HMO (health maintenance organization) in Massachusetts. Understanding the factors that contribute to the childhood obesity epidemic in order to identify intervention strategies is a critical public health need, given that obesity is a known risk factor for diabetes and other chronic conditions such as heart disease (Reilly and Kelly 2011). Diabetes incidence, both type 1 (T1D) and type 2 (T2D), is also on the rise [; Centers for Disease Control and Prevention (CDC) 2011;; ]. Based on data from the period 2005–2008, 25.6 million (11.3%) of all people in the United States ≥ 20 years of age have diagnosed or undiagnosed diabetes. Although it is estimated that 70% of T2D can be attributed to being overweight or obese, 30% of cases are not attributable to obesity. Therefore, factors other than changes in physical activity or diet may be contributing to this rise in childhood obesity and metabolic disorders. Indeed, there is growing concern that perinatal exposure to chemical insults may play a significant role in the increased incidence of obesity and metabolic disorders including diabetes, possibly through direct “diabetogenic” effects or by acting as “obesogens.”

Research addressing the role of environmental chemicals in childhood obesity and diabetes has rapidly expanded in the past several years. The, the National Institutes of Health (NIH) Obesity Research Task Force (2011), and the Diabetes Strategic Plan from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK 2011) all acknowledge the growing science base in this area and cite the need to understand more about the role of environmental exposures as part of future research and prevention strategies.

To help develop such a research strategy, the National Toxicology Program organized a state-of-the-science workshop in January 2011 titled “Role of Environmental Chemicals in the Development of Diabetes and Obesity”. This review derives from discussions that occurred during that workshop.

Identification of Relevant Studies

A PubMed (http://www.ncbi.nlm.nih.gov/pubmed) search strategy updated through 8 March 2012 was developed to identify human and animal studies related to maternal smoking or tobacco exposure during pregnancy and a) weight, growth, or adiposity after infancy (≥ 1 year of age in humans, after postnatal day 21 in rodents), or b) health outcomes in offspring at any age related to T1D or T2D, glycemic control, or metabolic syndrome. Studies assessing growth in infants < 1 year of age were excluded because maternal smoking during pregnancy is a known risk factor for low birth weight, whereas the primary question being addressed at the workshop was whether maternal smoking is a risk factor for childhood obesity. The literature search included both MeSH-based and key word strategies to identify articles not yet indexed in PubMed [see Supplemental Material for a complete list of search terms (http://dx.doi.org/10.1289/ehp.1205404)]. This search identified a total of 1,551 publications (see Supplemental Material, Figure S1). Of these, 99 studies presented original data that met our inclusion criteria and were considered relevant as the primary literature. Two additional epidemiological studies identified during the peer-review process were also included for a total of 101 studies (83 human studies and 18 animal studies).

Maternal Smoking during Pregnancy

Offspring overweight or obesity. Smoking during pregnancy is a known risk factor for low birth weight and small-for-gestational-age infants, but is increasingly accepted as a risk factor for childhood overweight and obesity based on the consistent positive associations reported among studies (Figure 1). Most studies (34 of 42) summarized in Figure 1 present results that support a causal link between maternal smoking and subsequent child overweight or obesity. Many of these studies were evaluated in two recent meta-analyses. Based on results reported in 14 observational studies, maternal smoking during pregnancy was associated with overweight at 3–33 years of age [pooled adjusted odds ratio (adjOR) = 1.50; 95% CI: 1.36, 1.65]. The pooled OR estimated by for obesity [body mass index (BMI) > 95th percentile] was 1.64 (95% CI: 1.42, 1.90) based on 16 studies. Women who smoked during pregnancy tended to weigh more, and tended to have lower socioeconomic status, have less education, and were less likely to breastfeed. Both meta-analyses used funnel plot methods to ascertain publication bias and concluded there was some evidence for publication bias, but not enough to negate the overall conclusion of increased risk.

Ethnicity may affect the association between maternal smoking and childhood obesity. A large retrospective study by of the PedNSS (Pediatric Nutrition Surveillance System) cohort found significant associations between maternal smoking and childhood obesity only in white (n = 66,191) and black (n = 28,230) children; the associations were not apparent for Hispanic (n = 34,378), American Indian/Alaska native (n = 2,228), or Asian/Pacific Islander children (n = 4,740). The lack of association in children of Asian/Pacific Island descent is interesting because studies on Japanese children have reported findings consistent with a positive relationship. Too few studies are available on Native American and Hispanic children to interpret the findings of in the context of other studies. One Brazilian study by did not find an association between maternal smoking and offspring overweight at 8–10 years of age (adjOR = 1.07; 95% CI: 0.84, 1.37); however, they did find that children of mothers who smoked were less likely to be underweight (adjOR = 0.56; 95% CI: 0.40, 0.78). It is worth noting that this study was conducted in the Ribeirao region of Brazil where 9.5% of the children were malnourished (BMI < 5th percentile).

Unmeasured confounding. Although the literature on the association between maternal smoking and obesity/overweight in children is fairly consistent when looking across studies, there are some indications that unmeasured familial or lifestyle factors may contribute to the association. One study conducted sibling-based analyses to evaluate the relationship between maternal smoking and BMI in 124,203 males born between 1983 and 1988, identified in the Swedish Medical Birth Registry with the intent of investigating the impact of familial factors on the association between maternal smoking and child obesity. They reported an association between maternal smoking during the first trimester and overweight (BMI ≥ 25) for the cohort as a whole (adjOR = 1.56; 95% CI: 1.46, 1.66 for > 10 cigarettes/day compared with 0 cigarettes). However, the authors found smaller associations based on within-family analyses, suggesting partial confounding by familial factors. also conducted a sibling-based analysis of children enrolled in the Collaborative Perinatal Project to address the issue of unmeasured confounding factors by fitting conditional fixed-effects models among siblings. This type of analysis capitalizes on variability in exposure to tobacco smoke that can occur among siblings when the mother’s smoking pattern during gestation differed across pregnancies. Conceptually, the sibling analysis matches exposed and unexposed siblings on family background to identify evidence of unmeasured sources of confounding. found significant positive associations in the full cohort for overweight at 7 years of age were still apparent in the conditional sibling fixed effects analysis.

Secondhand smoke exposure during pregnancy or childhood. Although the literature search strategy and inclusion criteria were constructed to identify studies assessing maternal smoking during pregnancy, several studies of paternal or “partner” smoking during pregnancy or during childhood were identified. Some of these studies reported no association between parental/partner smoking and BMI or adiposity end points whereas others did, suggesting that paternal/partner smoking may be a contributing factor on its own, either by unmeasured familial factors, or as a contributor to maternal exposure from secondhand smoke. Another study by assessed predictors of obesity at 8 years of age in 1,687 children participating in the Prevention and Incidence of Asthma and Mite Allergy (PIAMA) study, a prospective study based in the Netherlands. Maternal smoking during pregnancy and “smoking in the parental house” were both included in the model selection, but only “smoking in the parental house” was selected as a significant independent predictor of childhood overweight.

Other measures of adiposity, BMI, and leptin. The findings discussed above focus on studies of associations between maternal smoking and overweight or obesity. Other studies have estimated associations between maternal smoking during pregnancy and continuous measures of BMI, standardized BMI (i.e., z-score or SD score), or body weight in the offspring [see Supplemental Material, Table S1 (http://dx.doi.org/10.1289/ehp.1205404)]. Overall, these studies have reported positive associations with maternal smoking during pregnancy and child BMI. There are also indications that the children of mothers who smoked during pregnancy display more rapid weight gain earlier in life.

Studies in the literature often assess obesity based on BMI, which is not necessarily a direct measure of adiposity because it does not distinguish fat and lean mass. Associations between maternal smoking and indicators of adiposity (i.e., body fat, abdominal fat, skin fold thickness) [see Supplemental Material, Table S2 (http://dx.doi.org/10.1289/ehp.1205404);;;;;; von Schnurbein et al. 2011] are less consistent than associations with overweight/obesity or continuous measures of BMI-related end points (Figure 1). Given the limitations of BMI as a measure of adiposity, it is therefore important for future studies to consider other more direct measures of adiposity/fat mass to clarify the contribution of maternal smoking to childhood obesity.

Leptin, a protein produced by adipocytes and placental tissue, appears to function as a link between adiposity, satiety, and energy regulation. Leptin levels have been correlated with neonatal growth, but very few studies have looked at leptin levels beyond the neonatal period, and it is unclear how informative the infant studies are for addressing issues related to childhood obesity, given the complex role that maternal smoking has on childhood growth (i.e., as a risk factor for low birth weight and for childhood obesity). Overall, the findings on leptin levels in cord blood or blood collected from infants in association with maternal smoking status are mixed, with some studies reporting positive associations, negative associations, or no association (; Kayemba-Kay’s et al. 2008;; ).

T1D. The existing human studies do not provide support for an association between maternal or paternal smoking during pregnancy and childhood T1D (Figure 2). Only 2 of the 13 studies assessing end points related to T1D following exposure during pregnancy reported findings consistent with an association. In the study by, the frequency of maternal smoking during pregnancy was higher in T1D cases compared with controls (37.2% vs. 24.8%, p = 0.023 or unadjusted OR = 1.79; 95% CI: 1.08, 2.97). Although the univariate finding was statistically significant, the authors did not include maternal smoking in the multivariate analysis conducted to identify risk factors for T1D. In the study by, a positive association was observed for one indicator of β-cell autoimmunity in T1D, tyrosine phosphatase (IA-2A) + antibody status (unadjusted OR = 1.6; 95% CI: 1.2, 2.2), and not for glutamic acid decarboxylase (GAD) + antibody status (data not shown). None of the five prospective studies reported a positive association between maternal or paternal smoking during pregnancy and T1D, including two studies of children who were considered at high risk for developing the disease. Several studies reported that T1D was less likely among children whose mothers smoked during pregnancy than among the children of nonsmoking mothers for T1D. reported a nonsignificant negative association between islet-cell antibodies (a marker of β-cell autoimmunity) and maternal smoking during pregnancy among children considered at high risk because one or both parents had T1D. However, the number of cases in this study was small (47 of 1,043 children). One hypothesis that may explain evidence of a protective effect of exposure to smoking relates to the hygiene theory of autoimmune disease; this suggests that the risk of autoimmune disease may be increased if the environment is “cleaner,” which might be manifest in the households of nonsmokers. Alternatively, smoking may affect immune function, resulting in a reduced risk of developing autoimmune disorder.

Although the overall literature does not support an association between maternal smoking during pregnancy and T1D in offspring, associations with exposure to smoke during childhood should be investigated further. Three studies have assessed childhood exposure and T1D, and both reported findings supportive of an association. In the study by, Lithuanian children who were islet-cell autoantibody positive were more likely to live in a home where family members smoked indoors than children who were islet-cell autoantibody negative [7 of 13 (53.8%) vs. 53 of 199 (26.6%), respectively, p = 0.004; unadjusted OR = 3.21; 95% CI: 1.03, 10.00]. The frequency of mothers who reported smoking during pregnancy did not differ between the groups in this study. reported that children with T1D were more likely to have been exposed to passive smoking than control children in Southern California [31 of 102 cases (30%) vs. 3 of 10 controls (10%), p = 0.0001; unadjusted OR = 3.90; 95% CI: 1.19, 17.24]. One limitation in the existing literature that needs to be addressed in future studies investigating the association of smoking or other environmental exposures and T1D is use of statistical models that consider potential confounding factors (e.g., viruses, nutrition, or socioeconomic psychosocial factors).

T2D and metabolic syndrome. Fewer studies have looked at associations between maternal smoking during pregnancy and T2D, blood glucose, blood insulin, or metabolic disease (Figure 3). It is not possible to reach conclusions with confidence based on the existing literature because of the variation in health outcomes assessed among the studies [i.e., HbA1C (hemoglobin A1C); fasting glucose, nonfasting glucose, HOMA-IR (homeostatic model assessment–insulin resistance), blood insulin; T2D; and metabolic syndrome. In addition, although most of the studies do not report positive associations with these outcomes, the age at assessment in many of the studies was relatively young, and additional follow-up may be required. It is worth noting that no association with HbA1C ≥ 6% was found in the oldest and largest cohort assessed [7,518 men and women from the 1958 British birth cohort enrolled in the Perinatal Mortality Survey (PMS) evaluated at 45 years of age]. This finding does not confirm an earlier report for the same cohort of an association between heavy smoking during pregnancy and T2D in offspring at 33 years of age (adjOR = 4.02; 95% CI: 1.14, 14.14). A related analysis of the cohort by also reported no association with HbA1C in adults at 45 years of age (fully adjusted mean difference = 0.13; 95% CI: –0.33, 0.58). reported a positive association between maternal smoking during pregnancy and metabolic syndrome based on an unadjusted model [unadjusted OR = 1.21; 95% CI: 1.05, 1.39), but there was a significant negative association between maternal smoking and metabolic syndrome after adjustment for adult life covariates such as social class, education, physical activity and inactivity (television/computer use), smoking, and consumption of fruit/vegetables, cakes/sweets, and alcohol (adjOR = 0.55; 95% CI: 0.47, 0.64).

Animal Studies on Developmental Exposure to Nicotine

There are 599 known cigarette additives, and most are uncharacterized for potential toxicity, including metabolic effects. One exception is cadmium, a constituent of tobacco of smoke shown to alter glucose homeostasis or insulin sensitivity in animals exposed as adults but has not been assessed for metabolic effects after developmental exposure. Only two studies assessed prenatal exposure to cigarette smoke during pregnancy and body weight later in life in offspring.

Body weight and adiposity. Most animal studies have reported that rats exposed to nicotine during perinatal development tended to have a higher body weight and more fat mass compared with controls (Figure 4), with the effect typically first apparent at weaning and persisting through adulthood. However, there are exceptions to this pattern, which do not appear to be attributable to strain differences, dosing, or the timing of exposure. Food intake was unaffected in studies that evaluated it as an end point. The potential interaction between perinatal nicotine exposure and postnatal diet has been explored in only one study, which examined whether a high-fat diet (HFD) postnatally would exacerbate the weight gain in nicotine-exposed animals. Although the nicotine-treated animals that were fed an HFD did not consume more kilocalories than controls fed the same diet, they were heavier. The nicotine-treated animals were less physically active than control animals that consumed the same diet. There were no differences in oxygen consumption or respiratory exchange ratio, suggesting that increased weight gain in HFD animals with the same caloric intake was perhaps attributable to the dysregulation of adipose tissue development, thereby leading to higher amounts of fat storage.

Glucose homeostasis and insulin sensitivity. There are several reports in the literature on impaired glucose homeostasis in the male offspring of rats that were treated with nicotine during gestation, lactation, or gestation and lactation (Figure 5). Administered doses ranged from 1 to 6 mg/kg-day delivered to the mother either via an osmotic minipump implanted under the skin or via daily subcutaneous injections. These dosing protocols resulted in maternal serum cotinine levels considered relevant to women who smoke or use nicotine patches as cigarette substitutes. The most consistent findings from these studies were indications of insulin resistance in adulthood based on increased insulin area under the curve (AUC) following an oral or intraperitoneal glucose challenge or on an increased insulin resistance index. These effects were seen across studies despite the use of different doses of nicotine, different administration protocols, and different windows of developmental exposure within the perinatal period (i.e., gestation and/or lactation). A study by, reported increased insulin resistance in 15-week-old F2 generation male offspring of dams that were treated with nicotine only during gestation and lactation compared with untreated controls. Impairments in glucose tolerance also have been reported following nicotine exposure. Effects on fasting insulin levels have been less consistent, with some studies showing no effect and others reporting increased levels in adult rodents compared with untreated controls. At low dose levels (1 mg/kg-day) permanent changes in glucose homeostasis were observed only when exposure occurred during both fetal and neonatal life (i.e., pregnancy and lactation); however, when dams were exposed to 3 mg/kg-day or 6 mg/kg-day, then either fetal or lactational exposure was sufficient to affect glycemic control. Importantly, no effects on glucose homeostasis were observed in Wistar rats or in a series of studies in Sprague-Dawley rats treated with nicotine after weaning. Taken together, these data suggest that cigarette smoke or nicotine exposure during gestation and lactation is the critical window of exposure.

Pancreatic effects. Changes in pancreatic weight, morphology, and function have been reported in animals that were treated with nicotine during gestation alone or during gestation and lactation (Figure 6). These pancreatic effects include increased β-cell apoptosis and decreased β-cell mass in rodents. Other findings include decreased pancreatic weight in infant rhesus monkeys. As noted earlier, the treatment protocols used in the rodent studies result in maternal serum cotinine levels that are considered relevant to women who smoke or use nicotine patches as cigarette substitutes. The pancreatic effects are hypothesized to occur as a direct effect of nicotine binding to nicotinic acetylcholine receptors in the developing pancreas, leading to oxidative stress and mitochondrial damage and eventual β-cell apoptosis. Pancreatic tissue is considered to be especially susceptible to oxidative stress–mediated tissue damage due to low levels of antioxidant enzyme expression.

Leptin signaling. Adipose tissue is increasingly recognized as an active endocrine organ with many secretory products. In addition, adipose tissue is considered to be part of the innate immune system. Leptin is one of the key hormones involved in feeding behavior and energy expenditure [reviewed by Belgardt et al. (2010)]. In general terms, leptin is secreted from the adipocytes of white adipose tissue and delivers information on peripheral energy stores to the central nervous system. Leptin resistance that involves impairment in leptin transport, leptin signaling, and/or the neurocircuitry of energy balance is a risk factor for obesity. Several studies have assessed leptin levels or the expression of proteins involved in leptin signaling after developmental nicotine exposure. Findings from animal studies reveal that early exposure to nicotine appears to be associated with dysregulation of leptin levels, likely via hypertrophy of adipocytes and increased gene expression of pro-adipogenic transcription factors and hypothalamic leptin signaling.

The association between smoking and leptin levels in human infants remains controversial, with both hyper- and hypoleptinemia being reported (;; Kayemba-Kay’s et al. 2008;;;,; ).

Conclusions and Research Recommendations

Based on human epidemiological studies and animal experiments reported in the literature, current evidence supports a causal relationship between maternal smoking and increased risk of obesity or overweight in offspring; however, the possibility that the association is attributable to unmeasured residual confounding cannot be completely ruled out. The literature is not sufficient to evaluate the potential impact of maternal smoking after delivery, or the contribution of exposure to secondhand smoke during pregnancy and early childhood. Existing studies in humans do not provide strong support for an association between maternal or parental smoking and childhood T1D, and too few epidemiological studies have assessed outcomes related to T2D to reach conclusions. However, findings from animal studies identify associations between perinatal nicotine exposure and disruption of pathways important in the pathophysiology of T2D, including reduced β-cell mass and impaired β-cell function.

In Appendix 1 we identify research gaps and provide specific study recommendations noting in particular the need to better understand the a) relationship between developmental exposure to tobacco smoke as a risk factor for T2D or metabolic syndrome, b) consequences of pre- and postnatal exposure to secondhand smoke (also called environmental tobacco smoke, involuntary smoke, and passive smoke), c) impact of timing of exposure, dose, duration and route (e.g., nicotine replacement therapy), and d) mechanistic basis for the association between cigarette smoke or nicotine exposure with childhood obesity and metabolic outcomes. Elucidating the mechanistic basis for these associations could be an important component of developing a toxicological screening approach that could be used to identify other environmental chemicals for targeted assessment of obesogenic and metabolic effects. For example, a number of pesticides included in Phase 1 of the U.S. Environmental Protection Agency (U.S. EPA 2012) ToxCast™ high throughput screening program interact with nicotinic receptors but have never been assessed for potential adipogenic or metabolic effects [see Supplemental Material, Figure S2 (http://dx.doi.org/10.1289/ehp.1205404)]. Addressing the data gaps can help us understand more about the nature of the association as well as inform decisions regarding intervention strategies. Epidemiological studies will also need to consider the challenges related to validity of self-reported maternal tobacco use or secondhand smoke exposure, especially in studies evaluating the long-term health consequences for offspring where exposure assessment may occur many years after the exposure event. With respect to mechanistic research, more attention should be given to the possibility that environmental exposures could alter central nervous system regulation of energy and body weight homeostasis. The brain is the primary organ involved with determining behavior and obesity; metabolic diseases are often considered to be manifestations of behavioral excess (i.e., consuming calories in excess of one’s energy needs). A number of pathways are important for the development of obesity and/or diabetes, including but not limited to alterations in neurohumoral signaling, feeding behavior, energy balance, brain and peripheral inflammation, and insulin resistance. To date, the effects of maternal cigarette smoking and/or nicotine exposure on these pathways remains largely unexplored. Another largely unexplored hypothesis is that fetal/neonatal exposure to smoking/nicotine sensitizes the offspring to adverse effects of obesogenic diets. Although perturbations in the microbiome profile have been associated with diabetes and obesity, the contribution of or interactions with smoking have not been explored and may also influence susceptibility to adverse diets.

The association between maternal smoking and childhood obesity adds to the recognized health burden from tobacco exposure, which is estimated at almost 5 million deaths per year globally. Maternal smoking during pregnancy may not account for as many cases of childhood obesity or overweight as more traditional risk factors such as decreased physical activity, watching television > 1 hr/day, and low parental education level, but it is a risk factor that, if prevented, can help reduce the burden of childhood obesity at the population level. From a toxicological perspective, the linkages between maternal smoking during pregnancy and childhood overweight/obesity provide proof-of-concept of how early-life exposure to an environmental toxicant can act as a risk factor for childhood obesity.

Appendix 1. Data Gaps and Research Needs

Epidemiology

Additional assessment of association between maternal smoking and risk of T2D and metabolic syndrome in offspring

Clarification of the pre- and postnatal consequences of secondhand smoke on childhood obesity and metabolic outcomes

Characterization of factors such as timing of exposure (including adolescence), dose, duration and route (e.g., nicotine replacement therapy)

Evaluate potential confounding by or interactions with postnatal diet and activity levels

Consider studies of nicotine replacement therapy (NRT) to better establish the association between nicotine and obesity or diabetes and other metabolic disorders in humans

––RT during pregnancy trials, NRT following smoking cessation, nicotine therapeutics for nonsmokers, Snus (a moist powder tobacco product similar to dry snuff)

––Other data may be available from FDA for nicotinic acetylcholine receptor agonist drugs, and putative “reduced” harm cigarettes

Animal and in vitro

Better understanding of the basic biology of critical cells (i.e., adipocytes, β cells) and their function in health and disease, including how the biology that controls body weight and metabolic set points change with life stage

Further characterize impact of factors such as timing of exposure, dose, duration, and route (e.g., NRT) on adiposity, diabetes, and metabolic-related health outcomes

Mechanistic effects of smoking on genomic/epigenomic and molecular targets that coordinate central and peripheral nutrient homeostasis and metabolic function

Determine the relative contribution of other constituents of cigarette smoke

––Graded step wise manner—starting with high throughput–type screening with relevant cell types, then in vivo alone, and then in vivo in combination with nicotine

Evaluate interactions between fetal/neonatal exposure to smoking/nicotine and postnatal diet and activity levels

Assess the effects of other chemicals that act as agonists for nicotinic acetylcholine receptors (nAChRs), such as neonicotinoid pesticides as well as chemicals identified in the U.S. EPA’s ToxCast™ high throughput screening program [see Supplemental Material Figure 2 (http://dx.doi.org/10.1289/ehp.1205404)].

References 144

  1. 1.

    Adams AK, Harvey HE, Prince RJ. Association of maternal smoking with overweight at age 3 y in American Indian children. Am J Clin Nutr. 2005;82(2):393-398.

    Not in our library10.1093/ajcn.82.2.393

  2. 2.

    Al Mamun A, Lawlor DA, Alati R, O’Callaghan MJ, Williams GM, Najman JM. Does maternal smoking during pregnancy have a direct effect on future offspring obesity? Evidence from a prospective birth cohort study. Am J Epidemiol. 2006;164(4):317-325.

    Not in our library10.1093/aje/kwj209

  3. 3.

    Belgardt BF, Bruning JC. CNS leptin and insulin action in the control of energy homeostasis. Ann NY Acad Sci. 2010;1212(1):97-113.

    Not in our library10.1111/j.1749-6632.2010.05799.x

  4. 4.

    Bergmann KE, Bergmann RL, Von Kries R, Bohm O, Richter R, Dudenhausen JW, et al. Early determinants of childhood overweight and adiposity in a birth cohort study: role of breast-feeding. Int J Obes Relat Metab Disord. 2003;27(2):162-172.

    Not in our library10.1038/sj.ijo.802200

  5. 5.

    Beyerlein A Toschke AM Schaffrath Rosario A von Kries R 2011 Risk factors for obesity: further evidence for stronger effects on overweight children and adolescents compared to normal-weight subjects.PLoS One61e15739; doi:[Online 20 January 2011]

    Not in our library10.1371/journal.pone.0015739

  6. 6.

    Beyerlein A, Toschke AM, von Kries R. Risk factors for childhood overweight: shift of the mean body mass index and shift of the upper percentiles: results from a cross-sectional study. Int J Obes (Lond). 2010;34(4):642-648.

    Not in our library10.1038/ijo.2009.301

  7. 7.

    Boerschmann H, Pfluger M, Henneberger L, Ziegler AG, Hummel S. Prevalence and predictors of overweight and insulin resistance in offspring of mothers with gestational diabetes mellitus. Diabetes Care. 2010;33(8):1845-1849.

    Not in our library10.2337/dc10-0139

  8. 8.

    Braun JM, Daniels JL, Poole C, Olshan AF, Hornung R, Bernert JT, et al. Prenatal environmental tobacco smoke exposure and early childhood body mass index. Paediatr Perinat Epidemiol. 2010;24(6):524-534.

    Not in our library10.1111/j.1365-3016.2010.01146.x

  9. 9.

    Bruin JE, Gerstein HC, Morrison KM, Holloway AC. Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria. Toxicol Sci. 2008a;103(2):362-370.

    Not in our library10.1093/toxsci/kfn012

  10. 10.

    Bruin JE, Kellenberger LD, Gerstein HC, Morrison KM, Holloway AC. Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying critical windows of exposure. J Endocrinol. 2007;194(1):171-178.

    Not in our library10.1677/joe-07-0050

  11. 11.

    Bruin JE, Petre MA, Lehman MA, Raha S, Gerstein HC, Morrison KM, et al. Maternal nicotine exposure increases oxidative stress in the offspring. Free Radic Biol Med. 2008b;44(11):1919-1925.

    Not in our library10.1016/j.freeradbiomed.2008.02.010

  12. 12.

    Bruin JE Petre MA Raha S Morrison KM Gerstein HC Holloway AC 2008c Fetal and neonatal nicotine exposure in Wistar rats causes progressive pancreatic mitochondrial damage and beta cell dysfunction.PLoS One310e3371; doi:[Online 8 October 2008]

    Not in our library10.1371/journal.pone.0003371

  13. 13.

    Diabetes Data and Trends. 2011.

    Not in our library

  14. 14.

    Chen A, Pennell ML, Klebanoff MA, Rogan WJ, Longnecker MP. Maternal smoking during pregnancy in relation to child overweight: follow-up to age 8 years. Int J Epidemiol. 2006;35(1):121-130.

    Not in our library10.1093/ije/dyi218

  15. 15.

    Chen H Iglesias MA Caruso V Morris MJ 2011 Maternal cigarette smoke exposure contributes to glucose intolerance and decreased brain insulin action in mice offspring independent of maternal diet.PloS one611e27260; doi:[Online 4 November 2011]

    Not in our library10.1371/journal.pone.0027260

  16. 16.

    Christou H, Connors JM, Ziotopoulou M, Hatzidakis V, Papathanassoglou E, Ringer SA, et al. Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab. 2001;86(2):935-938.

    Not in our library10.1210/jcem.86.2.7217

  17. 17.

    Coutant R, Boux de Casson F, Douay O, Mathieu E, Rouleau S, Beringue F, et al. Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: possible implications for birth weight. J Clin Endocrinol Metab. 2001;86(10):4854-4859.

    Not in our library10.1210/jcem.86.10.7971

  18. 18.

    Cupul-Uicab LA, Skjaerven R, Haug K, Melve KK, Engel SM, Longnecker MP. In utero exposure to maternal tobacco smoke and subsequent obesity, hypertension, and gestational diabetes among women in the MoBa cohort. Environ Health Perspect. 2011;120(3):355-360.

    Not in our library10.1289/ehp.1103789

  19. 19.

    Dahlquist G, Kallen B. Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(7):671-675.

    Not in our library10.1007/bf00400261

  20. 20.

    Dahlquist GG, Nystrom L, Patterson CC. Incidence of type 1 diabetes in Sweden among individuals aged 0–34 years, 1983–2007: an analysis of time trends. Diabetes Care. 2011;34(8):1754-1759.

    Not in our library10.2337/dc11-0056

  21. 21.

    DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabet Med. 2006;23(8):857-866.

    Not in our library10.1111/j.1464-5491.2006.01925.x

  22. 22.

    Dubois L, Girard M. Early determinants of overweight at 4.5 years in a population-based longitudinal study. Int J Obes (Lond). 2006;30(4):610-617.

    Not in our library10.1038/sj.ijo.0803141

  23. 23.

    Durmus B, Ay L, Hokken-Koelega AC, Raat H, Hofman A, Steegers EA, et al. Maternal smoking during pregnancy and subcutaneous fat mass in early childhood. The Generation R Study. Eur J Epidemiol. 2011a;26(4):295-304.

    Not in our library10.1007/s10654-010-9544-3

  24. 24.

    Durmus B, Kruithof CJ, Gillman MH, Willemsen SP, Hofman A, Raat H, et al. Parental smoking during pregnancy, early growth, and risk of obesity in preschool children: the Generation R Study. Am J Clin Nutr. 2011b;94(1):164-171.

    Not in our library10.3945/ajcn.110.009225

  25. 25.

    Edwards JR, Prozialeck WC. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol. 2009;238(3):289-293.

    Not in our library10.1016/j.taap.2009.03.007

  26. 26.

    Eyre H, Kahn R, Robertson RM. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. CA Cancer J Clin. 2004;54(4):190-207.

    Not in our library10.3322/canjclin.54.4.190

  27. 27.

    Fasting MH, Oien T, Storro O, Nilsen TI, Johnsen R, Vik T. Maternal smoking cessation in early pregnancy and offspring weight status at four years of age. A prospective birth cohort study. Early Hum Devel. 2009;85(1):19-24.

    Not in our library10.1016/j.earlhumdev.2008.05.009

  28. 28.

    Freedman DS, Sherry B. The validity of BMI as an indicator of body fatness and risk among children. Pediatrics. 2009;124(suppl 1):S23-S34.

    Not in our library10.1542/peds.2008-3586e

  29. 29.

    Gao YJ, Holloway AC, Su LY, Takemori K, Lu C, Lee RM. Effects of fetal and neonatal exposure to nicotine on blood pressure and perivascular adipose tissue function in adult life. Eur J Pharmacol. 2008;590(1–3):264-268.

    Not in our library10.1016/j.ejphar.2008.05.044

  30. 30.

    Gao YJ, Holloway AC, Zeng ZH, Lim GE, Petrik JJ, Foster WG, et al. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes Res. 2005;13(4):687-692.

    Not in our library10.1038/oby.2005.77

  31. 31.

    Gaspari L, Paris F, Jandel C, Kalfa N, Orsini M, Daures JP, et al. Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case-control study. Hum Reprod. 2011;26(11):3155-3162.

    Not in our library10.1093/humrep/der283

  32. 32.

    Gillman MW, Rifas-Shiman SL, Kleinman K, Oken E, Rich-Edwards JW, Taveras EM. Developmental origins of childhood overweight: potential public health impact. Obesity. 2008;16(7):1651-1656.

    Not in our library10.1038/oby.2008.260

  33. 33.

    Gilman SE, Gardener H, Buka SL. Maternal smoking during pregnancy and children’s cognitive and physical development: a causal risk factor? Am J Epidemiol. 2008;168(5):522-531.

    Not in our library10.1093/aje/kwn175

  34. 34.

    Goldani MZ, Haeffner LS, Agranonik M, Barbieri MA, Bettiol H, Silva AA. Do early life factors influence body mass index in adolescents? Braz J Med Biol Res. 2007;40(9):1231-1236.

    Not in our library10.1590/s0100-879x2006005000131

  35. 35.

    Gorog K, Pattenden S, Antova T, Niciu E, Rudnai P, Scholtens S, et al. Maternal smoking during pregnancy and childhood obesity: results from the CESAR study. Matern Child Health J. 2009;15(7):985-992.

    Not in our library10.1007/s10995-009-0543-5

  36. 36.

    Griffiths LJ, Hawkins SS, Cole TJ, Dezateux C. Risk factors for rapid weight gain in preschool children: findings from a UK-wide prospective study. Int J Obes (Lond). 2010;34(4):624-632.

    Not in our library10.1038/ijo.2010.10

  37. 37.

    Grove KL, Sekhon HS, Brogan RS, Keller JA, Smith MS, Spindel ER. Chronic maternal nicotine exposure alters neuronal systems in the arcuate nucleus that regulate feeding behavior in the newborn rhesus macaque. J Clin Endocrinol Metab. 2001;86(11):5420-5426.

    Not in our library10.1210/jcem.86.11.8033

  38. 38.

    Hackman R, Kapur B, Koren G. Use of the nicotine patch by pregnant women. New Engl J Med. 1999;341(22):1700.

    Not in our library10.1056/nejm199911253412216

  39. 39.

    Hathout EH, Beeson WL, Ischander M, Rao R, Mace JW. Air pollution and type 1 diabetes in children. Pediatr Diabetes. 2006;7(2):81-87.

    Not in our library10.1111/j.1399-543x.2006.00150.x

  40. 40.

    Helland IB, Reseland JE, Saugstad OD, Drevon CA. Smoking related to plasma leptin concentration in pregnant women and their newborn infants. Acta Paediatr. 2001;90(3):282-287.

    Not in our library

  41. 41.

    Hill SY, Shen S, Locke Wellman J, Rickin E, Lowers L. Offspring from families at high risk for alcohol dependence: increased body mass index in association with prenatal exposure to cigarettes but not alcohol. Psychiatry Res. 2005;135(3):203-216.

    Not in our library10.1016/j.psychres.2005.04.003

  42. 42.

    Holloway AC, Cuu DQ, Morrison KM, Gerstein HC, Tarnopolsky MA. Transgenerational effects of fetal and neonatal exposure to nicotine. Endocrine. 2007;31(3):254-259.

    Not in our library10.1007/s12020-007-0043-6

  43. 43.

    Holloway AC, Lim GE, Petrik JJ, Foster WG, Morrison KM, Gerstein HC. Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes. Diabetologia. 2005;48(12):2661-2666.

    Not in our library10.1007/s00125-005-0022-5

  44. 44.

    Horta BL, Gigante DP, Nazmi A, Silveira VM, Oliveira I, Victora CG. Maternal smoking during pregnancy and risk factors for cardiovascular disease in adulthood. Atherosclerosis. 2011;219:815-820.

    Not in our library10.1016/j.atherosclerosis.2011.08.018

  45. 45.

    Huang LZ, Winzer-Serhan UH. Nicotine regulates mRNA expression of feeding peptides in the arcuate nucleus in neonatal rat pups. Dev Neurobiol. 2007;67(3):363-377.

    Not in our library10.1002/dneu.20348

  46. 46.

    Huang RC, Burke V, Newnham JP, Stanley FJ, Kendall GE, Landau LI, et al. Perinatal and childhood origins of cardiovascular disease. Int J Obes (Lond). 2007;31(2):236-244.

    Not in our library10.1038/sj.ijo.0803394

  47. 47.

    Hummel M, Schenker M, Ziegler AG. Influence of perinatal factors on the appearance of islet autoantibodies in offspring of parents with type 1 diabetes. Pediatr Diabetes. 2001;2(1):40-42.

    Not in our library10.1046/j.1399-543x.2001.00000.x

  48. 48.

    Iliadou AN, Koupil I, Villamor E, Altman D, Hultman C, Langstrom N, et al. Familial factors confound the association between maternal smoking during pregnancy and young adult offspring overweight. Int J Epidemiol. 2010;39(5):1193-1202.

    Not in our library10.1093/ije/dyq064

  49. 49.

    Ino T. Maternal smoking during pregnancy and offspring obesity: meta-analysis. Pediatr Int. 2010;52(1):94-99.

    Not in our library10.1111/j.1442-200x.2009.02883.x

  50. 50.

    Ino T, Shibuya T, Saito K, Ohtani T. Effects of maternal smoking during pregnancy on body composition in offspring. Pediatr Int. 2011;53(6):851-857.

    Not in our library10.1111/j.1442-200x.2011.03383.x

  51. 51.

    Johansson A, Hermansson G, Ludvigsson J. Tobacco exposure and diabetes-related autoantibodies in children: results from the ABIS study. Ann NY Acad Sci. 2008;1150:197-199.

    Not in our library10.1196/annals.1447.023

  52. 52.

    Jose AS, Franciscato C, Sonego F, Figueiro M, Thiesen FV, Garcia SC, et al. Sensitivity of young rats to nicotine exposure: Physiological and biochemical parameters. Ecotoxicol Environ Saf. 2009;72(1):242-247.

    Not in our library10.1016/j.ecoenv.2008.03.010

  53. 53.

    Kanellopoulos TA, Varvarigou AA, Karatza AA, Beratis NG. Course of growth during the first 6 years in children exposed in utero to tobacco smoke. Eur J Pediatr. 2007;166(7):685-692.

    Not in our library10.1007/s00431-006-0308-8

  54. 54.

    Karaolis-Danckert N, Buyken AE, Kulig M, Kroke A, Forster J, Kamin W, et al. How pre- and postnatal risk factors modify the effect of rapid weight gain in infancy and early childhood on subsequent fat mass development: results from the Multicenter Allergy Study 90. Am J Clin Nutr. 2008;87(5):1356-1364.

    Not in our library10.1093/ajcn/87.5.1356

  55. 55.

    Kayemba-Kay’s S, Geary MP, Pringle J, Rodeck CH, Kingdom JC, Hindmarsh PC. 2008 Gender, smoking during pregnancy and gestational age influence cord leptin concentrations in newborn infants.Eur J Endocrinol1593217224

    Not in our library10.1530/eje-08-0171

  56. 56.

    Kim J, Peterson KE, Scanlon KS, Fitzmaurice GM, Must A, Oken E, et al. Trends in overweight from 1980 through 2001 among preschool-aged children enrolled in a health maintenance organization. Obesity (Silver Spring). 2006;14(7):1107-1112.

    Not in our library10.1038/oby.2006.126

  57. 57.

    Koshy G, Delpisheh A, Brabin BJ. Dose response association of pregnancy cigarette smoke exposure, childhood stature, overweight and obesity. Eur J Public Health. 2011;21(3):286-291.

    Not in our library10.1093/eurpub/ckq173

  58. 58.

    Koupil I, Toivanen P. Social and early-life determinants of overweight and obesity in 18-year-old Swedish men. Int J Obes (Lond). 2008;32(1):73-81.

    Not in our library10.1038/sj.ijo.0803681

  59. 59.

    Kuhle S, Allen AC, Veugelers PJ. Perinatal and childhood risk factors for overweight in a provincial sample of Canadian Grade 5 students. Int J Pediatr Obes. 2010;5(1):88-96.

    Not in our library10.3109/17477160903060028

  60. 60.

    Kwok MK, Schooling CM, Lam TH, Leung GM. Paternal smoking and childhood overweight: evidence from the Hong Kong “Children of 1997.”. Pediatrics. 2010;126(1):e46-56.

    Not in our library10.1542/peds.2009-2642

  61. 61.

    Leary SD, Smith GD, Rogers IS, Reilly JJ, Wells JC, Ness AR. Smoking during pregnancy and offspring fat and lean mass in childhood. Obesity (Silver Spring). 2006;14(12):2284-2293.

    Not in our library10.1038/oby.2006.268

  62. 62.

    Lee MJ, Fried SK. Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion. Am J Physiol Endocrinol Metab. 2009;296(6):E1230-E1238.

    Not in our library10.1152/ajpendo.90927.2008

  63. 63.

    Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med. 1996;20(3):463-466.

    Not in our library10.1016/0891-5849(96)02051-5

  64. 64.

    Lumley J Chamberlain C Dowswell T Oliver S Oakley L Watson L. 2008 Interventions for promoting smoking cessation during pregnancy.Cochrane Database Syst Rev18:(4CD001055; DOI: [Online 27 July 1998; last assessed as up to date, 4 December 2008]

    Not in our library10.1002/14651858.cd001055.pub3

  65. 65.

    Mantzoros CS, Varvarigou A, Kaklamani VG, Beratis NG, Flier JS. Effect of birth weight and maternal smoking on cord blood leptin concentrations of full-term and preterm newborns. J Clin Endocrinol Metab. 1997;82(9):2856-2861.

    Not in our library10.1210/jcem.82.9.4248

  66. 66.

    Marshall AL, Chetwynd A, Morris JA, Placzek M, Smith C, Olabi A, et al. Type 1 diabetes mellitus in childhood: a matched case control study in Lancashire and Cumbria, UK. Diabet Med. 2004;21(9):1035-1040.

    Not in our library10.1111/j.1464-5491.2004.01282.x

  67. 67.

    Matijasevich A, Brion MJ, Menezes AM, Barros AJ, Santos IS, Barros FC. Maternal smoking during pregnancy and offspring growth in childhood: 1993 and 2004 Pelotas cohort studies. Arch Dis Child. 2011;96(6):519-525.

    Not in our library10.1136/adc.2010.191098

  68. 68.

    Mendez MA, Torrent M, Ferrer C, Ribas-Fito N, Sunyer J. Maternal smoking very early in pregnancy is related to child overweight at age 5–7 y. Am J Clin Nutr. 2008;87(6):1906-1913.

    Not in our library10.1093/ajcn/87.6.1906

  69. 69.

    Mizutani T, Suzuki K, Kondo N, Yamagata Z. Association of maternal lifestyles including smoking during pregnancy with childhood obesity. Obesity (Silver Spring). 2007;15(12):3133-3139.

    Not in our library10.1038/oby.2007.373

  70. 70.

    Montgomery SM, Ekbom A. Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ. 2002;324(7328):26-27.

    Not in our library10.1136/bmj.324.7328.26

  71. 71.

    Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab. 2009;297(6):E1247-1259.

    Not in our library10.1152/ajpendo.00274.2009

  72. 72.

    NTP Workshop: Role of Environmental Chemicals in the Development of Diabetes and Obesity. 2011.

    Not in our library

  73. 73.

    Newman MB, Shytle RD, Sanberg PR. Locomotor behavioral effects of prenatal and postnatal nicotine exposure in rat offspring. Behav Pharmacol. 1999;10(6–7):699-706.

    Not in our library10.1097/00008877-199911000-00017

  74. 74.

    Ng SP, Conklin DJ, Bhatnagar A, Bolanowski DD, Lyon J, Zelikoff JT, et al. Prenatal exposure to cigarette smoke induces diet- and sex-dependent dyslipidemia and weight gain in adult murine offspring. Environ Health Perspect. 2009;117:1042-1048.

    Not in our library10.1289/ehp.0800193

  75. 75.

    Diabetes Research Strategic Plan. 2011.

    Not in our library

  76. 76.

    Strategic Plan for NIH Obesity Research. 2011.

    Not in our library

  77. 77.

    Prevalence of Obesity Among Children and Adolescents: United States, Trends 1963–1965 Through 2007–2008. CDC-NCHS Health E-Stat. 2010.

    Not in our library

  78. 78.

    Oken E, Huh SY, Taveras EM, Rich-Edwards JW, Gillman MW. Associations of maternal prenatal smoking with child adiposity and blood pressure. Obes Res. 2005;13(11):2021-2028.

    Not in our library10.1038/oby.2005.248

  79. 79.

    Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond). 2008;32(2):201-210.

    Not in our library10.1038/sj.ijo.0803760

  80. 80.

    Oliveira E, Moura EG, Santos-Silva AP, Fagundes AT, Rios AS, Abreu-Villaca Y, et al. Short- and long-term effects of maternal nicotine exposure during lactation on body adiposity, lipid profile, and thyroid function of rat offspring. J Endocrinol. 2009;202(3):397-405.

    Not in our library10.1677/joe-09-0020

  81. 81.

    Oliveira E, Moura EG, Santos-Silva AP, Pinheiro CR, Lima N, Nogueira-Neto J, et al. Neonatal nicotine exposure causes insulin and leptin resistance and inhibits hypothalamic leptin signaling in adult rat offspring. J Endocrinol. 2010;206(1):55-63.

    Not in our library10.1677/joe-10-0104

  82. 82.

    Ozkan B, Ermis B, Tastekin A, Doneray H, Yildirim A, Ors R. Effect of smoking on neonatal and maternal serum and breast milk leptin levels. Endocr Res. 2005;31(3):177-183.

    Not in our library10.1080/07435800500371748

  83. 83.

    Pardo IM, Geloneze B, Tambascia MA, Barros AA. Inverse relationship between cord blood adiponectin concentrations and the number of cigarettes smoked during pregnancy. Diabetes Obes Metab. 2005;7(2):144-147.

    Not in our library10.1111/j.1463-1326.2004.00379.x

  84. 84.

    Pardo IM, Geloneze B, Tambascia MA, Barros-Filho AA. Does maternal smoking influence leptin levels in term, appropriate-for-gestational-age newborns? J Matern Fetal Neonatal Med. 2004;15(6):408-410.

    Not in our library10.1080/14767050410001680046

  85. 85.

    Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009;373(9680):2027-2033.

    Not in our library10.1016/s0140-6736(09)60568-7

  86. 86.

    Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;269(5223):540-543.

    Not in our library10.1126/science.7624776

  87. 87.

    Power C, Atherton K, Thomas C. Maternal smoking in pregnancy, adult adiposity and other risk factors for cardiovascular disease. Atherosclerosis. 2010;211(2):643-648.

    Not in our library10.1016/j.atherosclerosis.2010.03.015

  88. 88.

    Power C, Jefferis BJ. Fetal environment and subsequent obesity: a study of maternal smoking. Int J Epidemiol. 2002;31(2):413-419.

    Not in our library

  89. 89.

    Prescott SL. Effects of early cigarette smoke exposure on early immune development and respiratory disease. Paediatr Respir Rev. 2008;9(1):3-9.

    Not in our library10.1016/j.prrv.2007.11.004

  90. 90.

    Rabinoff M, Caskey N, Rissling A, Park C. Pharmacological and chemical effects of cigarette additives. Am J Public Health. 2007;97(11):1981-1991.

    Not in our library10.2105/ajph.2005.078014

  91. 91.

    Raum E, Kupper-Nybelen J, Lamerz A, Hebebrand J, Herpertz-Dahlmann B, Brenner H. Tobacco smoke exposure before, during, and after pregnancy and risk of overweight at age 6. Obesity (Silver Spring, Md). 2011;19(12):2411-2417.

    Not in our library10.1038/oby.2011.129

  92. 92.

    Ravnborg TL, Jensen TK, Andersson AM, Toppari J, Skakkebaek NE, Jorgensen N. Prenatal and adult exposures to smoking are associated with adverse effects on reproductive hormones, semen quality, final height and body mass index. Hum Reprod. 2011;26(5):1000-1011.

    Not in our library10.1093/humrep/der011

  93. 93.

    Reilly JJ, Armstrong J, Dorosty AR, Emmett PM, Ness A, Rogers I, et al. Early life risk factors for obesity in childhood: Cohort study. BMJ. 2005;330(7504):1357.

    Not in our library10.1136/bmj.38470.670903.e0

  94. 94.

    Reilly JJ Kelly J 2011. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review.Int J Obes (2005 ) 357891898

    Not in our library10.1038/ijo.2010.222

  95. 95.

    Robertson L Harrild K. 2010 Maternal and neonatal risk factors for childhood type 1 diabetes: a matched case-control study.BMC Public Health10281; doi:[Online 27 May 2010]

    Not in our library10.1186/1471-2458-10-281

  96. 96.

    Rooney BL, Mathiason MA, Schauberger CW. Predictors of obesity in childhood, adolescence, and adulthood in a birth cohort. Matern Child Health J. 2010;15(8):1166-1175.

    Not in our library10.1007/s10995-010-0689-1

  97. 97.

    Rosenbauer J, Herzig P, Kaiser P, Giani G. Early nutrition and risk of type 1 diabetes mellitus—a nationwide case-control study in preschool children. Exp Clin Endocrinol Diabetes. 2007;115(8):502-508.

    Not in our library10.1055/s-2007-973829

  98. 98.

    Salsberry PJ, Reagan PB. Dynamics of early childhood overweight. Pediatrics. 2005;116(6):1329-1338.

    Not in our library10.1542/peds.2004-2583

  99. 99.

    Salsberry PJ, Reagan PB. Taking the long view: the prenatal environment and early adolescent overweight. Res Nurs Health. 2007;30(3):297-307.

    Not in our library10.1002/nur.20215

  100. 100.

    Samper MP, Jimenez-Muro A, Nerin I, Marqueta A, Ventura P, Rodriguez G. Maternal active smoking and newborn body composition. Early Hum Dev. 2011;88(3):141-145.

    Not in our library10.1016/j.earlhumdev.2011.07.015

  101. 101.

    Santos-Silva AP, Moura EG, Pinheiro CR, Rios AS, Abreu-Villaca Y, Passos MC, et al. Neonatal nicotine exposure alters leptin signaling in the hypothalamus-pituitary-thyroid axis in the late postnatal period and adulthood in rats. Life Sci. 2010;87(5–6):187-195.

    Not in our library10.1016/j.lfs.2010.06.012

  102. 102.

    Santos-Silva AP, Oliveira E, Pinheiro CR, Nunes-Freitas AL, Abreu-Villaca Y, Santana AC, et al. Effects of tobacco smoke exposure during lactation on nutritional and hormonal profiles in mothers and offspring. J Endocrinol. 2011;209(1):75-84.

    Not in our library10.1530/joe-10-0410

  103. 103.

    Sharma AJ, Cogswell ME, Li R. Dose-response associations between maternal smoking during pregnancy and subsequent childhood obesity: effect modification by maternal race/ethnicity in a low-income US cohort. Am J Epidemiol. 2008;168(9):995-1007.

    Not in our library10.1093/aje/kwn223

  104. 104.

    Silva AA, Vasconcelos AG, Bettiol H, Barbieri MA. Socioeconomic status, birth weight, maternal smoking during pregnancy and adiposity in early adult life: an analysis using structural equation modeling. Cad Saude Publica. 2010;26(1):15-29.

    Not in our library10.1590/s0102-311x2010000100003

  105. 105.

    Sipetic SB, Vlajinac HD, Kocev NI, Marinkovic JM, Radmanovic SZ, Bjekic MD. The Belgrade childhood diabetes study: a multivariate analysis of risk determinants for diabetes. Eur J Public Health. 2005;15(2):117-122.

    Not in our library10.1093/eurpub/cki074

  106. 106.

    Skrodeniene E, Marciulionyte D, Padaiga Z, Jasinskiene E, Sadauskaite-Kuehne V, Ludvigsson J. Environmental risk factors in prediction of childhood prediabetes. Medicina (Kaunas). 2008;44(1):56-63.

    Not in our library

  107. 107.

    Somm E, Schwitzgebel VM, Vauthay DM, Aubert ML, Huppi PS. Prenatal nicotine exposure and the programming of metabolic and cardiovascular disorders. Mol Cell Endocrinol. 2009;304(1–2):69-77.

    Not in our library10.1016/j.mce.2009.02.026

  108. 108.

    Somm E, Schwitzgebel VM, Vauthay DM, Camm EJ, Chen CY, Giacobino JP, et al. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology. 2008;149(12):6289-6299.

    Not in our library10.1210/en.2008-0361

  109. 109.

    Stene LC, Barriga K, Norris JM, Hoffman M, Erlich HA, Eisenbarth GS, et al. Perinatal factors and development of islet autoimmunity in early childhood: the diabetes autoimmunity study in the young. Am J Epidemiol. 2004;160(1):3-10.

    Not in our library10.1093/aje/kwh159

  110. 110.

    Steur M, Smit HA, Schipper CM, Scholtens S, Kerkhof M, de Jongste JC, et al2010 Predicting the risk of newborn children to become overweight later in childhood: The PIAMA birth cohort study. Int J Pediatr Obes 6(2-2):e170–e178.

    Not in our library10.3109/17477166.2010.519389

  111. 111.

    Suzuki K, Ando D, Sato M, Tanaka T, Kondo N, Yamagata Z. The association between maternal smoking during pregnancy and childhood obesity persists to the age of 9–10 years. J Epidemiol. 2009;19(3):136-142.

    Not in our library10.2188/jea.je20081012

  112. 112.

    Suzuki K, Kondo N, Sato M, Tanaka T, Ando D, Yamagata Z. Gender differences in the association between maternal smoking during pregnancy and childhood growth trajectories: multilevel analysis. Int J Obes (Lond). 2011;35(1):53-59.

    Not in our library10.1038/ijo.2010.198

  113. 113.

    Svensson J, Carstensen B, Mortensen HB, Borch-Johnsen K. Early childhood risk factors associated with type 1 diabetes—is gender important? Eur J Epidemiol. 2005;20(5):429-434.

    Not in our library10.1007/s10654-005-0878-1

  114. 114.

    Swislocki AL. Smokeless nicotine administration does not result in hypertension or a deterioration in glucose tolerance or insulin sensitivity in juvenile rats. Metabolism. 2003;52(1):67-72.

    Not in our library10.1053/meta.2003.50006

  115. 115.

    Swislocki AL, Fakiri Z. Smokeless nicotine exposure has no lasting effect on fasting or postglucose circulation leptin in young rats. Metab Syndr Relat Disord. 2008;6(4):257-262.

    Not in our library10.1089/met.2008.0017

  116. 116.

    Swislocki AL, Tsuzuki A, Tait M, Khuu D, Fann K. Smokeless nicotine administration is associated with hypertension but not with a deterioration in glucose tolerance in rats. Metabolism. 1997;46(9):1008-1012.

    Not in our library10.1016/s0026-0495(97)90270-5

  117. 117.

    Syme C, Abrahamowicz M, Mahboubi A, Leonard GT, Perron M, Richer L, et al. Prenatal exposure to maternal cigarette smoking and accumulation of intra-abdominal fat during adolescence. Obesity (Silver Spring). 2010;18(5):1021-1025.

    Not in our library10.1038/oby.2009.354

  118. 118.

    Thiering E, Bruske I, Kratzsch J, Thiery J, Sausenthaler S, Meisinger C, et al. Prenatal and postnatal tobacco smoke exposure and development of insulin resistance in 10 year old children. Int J Hyg Environ Health. 2011;214:361-368.

    Not in our library10.1016/j.ijheh.2011.04.004

  119. 119.

    Thomas C, Hypponen E, Power C. Prenatal exposures and glucose metabolism in adulthood: are effects mediated through birth weight and adiposity? Diabetes Care. 2007;30(4):918-924.

    Not in our library10.2337/dc06-1881

  120. 120.

    Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes. 1997;46(11):1733-1742.

    Not in our library10.2337/diab.46.11.1733

  121. 121.
    Are birth weight and maternal smoking during pregnancy associated with malnutrition and excess weight among school age children?
    Not checked
  122. 122.

    Toschke AM, Ehlin A, Koletzko B, Montgomery SM. Paternal smoking is associated with a decreased prevalence of type 1 diabetes mellitus among offspring in two national British birth cohort studies (NCDS and BCS70). J Perinat Med. 2007a;35(1):43-47.

    Not in our library10.1515/jpm.2007.006

  123. 123.

    Toschke AM, Koletzko B, Slikker W, Hermann M, von Kries R. Childhood obesity is associated with maternal smoking in pregnancy. Eur J Pediatr. 2002;161(8):445-448.

    Not in our library10.1007/s00431-002-0983-z

  124. 124.

    Toschke AM, Montgomery SM, Pfeiffer U, von Kries R. Early intrauterine exposure to tobacco-inhaled products and obesity. Am J Epidemiol. 2003;158(11):1068-1074.

    Not in our library10.1093/aje/kwg258

  125. 125.

    Toschke AM, Ruckinger S, Bohler E, Von Kries R. Adjusted population attributable fractions and preventable potential of risk factors for childhood obesity. Public Health Nutr. 2007b;10(9):902-906.

    Not in our library10.1017/s136898000725846x

  126. 126.

    ToxCast™. 2012.

    Not in our library

  127. 127.

    Vatten LJ, Nilsen ST, Odegard RA, Romundstad PR, Austgulen R. Insulin-like growth factor I and leptin in umbilical cord plasma and infant birth size at term. Pediatrics. 2002;109(6):1131-1135.

    Not in our library10.1542/peds.109.6.1131

  128. 128.

    Vik T, Jacobsen G, Vatten L, Bakketeig LS. Pre- and post-natal growth in children of women who smoked in pregnancy. Early Hum Dev. 1996;45(3):245-255.

    Not in our library10.1016/0378-3782(96)01735-5

  129. 129.

    von Kries R, Bolte G, Baghi L, Toschke AM, GMESG. Parental smoking and childhood obesity—is maternal smoking in pregnancy the critical exposure? Int J Epidemiol. 2008;37(1):210-216.

    Not in our library10.1093/ije/dym239

  130. 130.

    von Kries R, Toschke AM, Koletzko B, Slikker W. Maternal smoking during pregnancy and childhood obesity. Am J Epidemiol. 2002;156(10):954-961.

    Not in our library10.1093/aje/kwf128

  131. 131.

    von Schnurbein J, Klenk J, Galm C, Berg S, Gottmann P, Steinacker JM, et al. Reference values and early determinants of intra-abdominal fat mass in primary school children. Horm Res Paediatr. 2011;75(6):412-422.

    Not in our library10.1159/000324110

  132. 132.

    Wadsworth EJ, Shield JP, Hunt LP, Baum JD. A case-control study of environmental factors associated with diabetes in the under 5s. Diabet Med. 1997;14(5):390-396.

    Not in our library10.1002/(sici)1096-9136(199705)14:5<390::aid-dia364>3.0.co;2-e

  133. 133.

    Wahlberg J, Vaarala O, Ludvigsson J. Asthma and allergic symptoms and type 1 diabetes-related autoantibodies in 2.5-yr-old children. Pediatr Diabetes. 2011;12(7):604-610.

    Not in our library10.1111/j.1399-5448.2011.00758.x

  134. 134.

    Wells JC. A critique of the expression of paediatric body composition data. Arch Dis Child. 2001;85(1):67-72.

    Not in our library10.1136/adc.85.1.67

  135. 135.

    Wen X, Triche EW, Hogan JW, Shenassa ED, Buka SL. Prenatal factors for childhood blood pressure mediated by intrauterine and/or childhood growth? Pediatrics. 2011;127(3):e713-e721.

    Not in our library10.1542/peds.2010-2000

  136. 136.

    Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics. 2004;114(1):e29-e36.

    Not in our library10.1542/peds.114.1.e29

  137. 137.

    Report to the President: Solving the Problem of Childhood Obesity Within a Generation. 2010.

    Not in our library10.1089/bfm.2010.9980

  138. 138.

    Widerøe M, Torstein V, Jacobsen G, Bakketeig L. Does maternal smoking during pregnancy cause childhood overweight? Paediatr Perinat Epidemiol. 2003;17(2):171-179.

    Not in our library10.1046/j.1365-3016.2003.00481.x

  139. 139.
    Obesity: Prevalence, Theories, Medical Consequences, Management, and Research Directions · 2005
    Not checked
  140. 140.

    Williams CM, Kanagasabai T. Maternal adipose tissue response to nicotine administration in the pregnant rat: effects on fetal body fat and cellularity. Br J Nutr. 1984;51(1):7-13.

    Not in our library10.1079/bjn19840004

  141. 141.

    Woods SC. The control of food intake: behavioral versus molecular perspectives. Cell Metab. 2009;9(6):489-498.

    Not in our library10.1016/j.cmet.2009.04.007

  142. 142.

    Woods SC, D’Alessio DA. Central control of body weight and appetite. J Clin Endocrinol Metab. 2008;93(11):S37-S50.

    Not in our library10.1210/jc.2008-1630

  143. 143.

    Global Status Report on Noncommunicable Diseases 2010. 2010.

    Not in our library

  144. 144.

    Zheng H, Lenard NR, Shin AC, Berthoud HR. Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals. Int J Obes (Lond). 2009;33(suppl 2):S8-S13.

    Not in our library10.1038/ijo.2009.65

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.